Li YH - Search Results

1

A 3-Year Survival Update from a Phase 2 Study of Paclitaxel Plus Cisplatin and 5-Fuorouracil Induction Chemotherapy for Locally Advanced Borderline-Resectable Esophageal Squamous Cell Carcinoma: The NEOCRTEC-1601 Clinical Trial.

Wu JD, Wang ZQ, Li QQ, Li ZC, Ren C, Wang DS, Chen JY, Tan Q, Li YH, Yang H. Wu JD, et al. Among authors: li yh, li qq, li zc. Ann Surg Oncol. 2024 Feb;31(2):838-846. doi: 10.1245/s10434-023-14513-0. Epub 2023 Nov 2. Ann Surg Oncol. 2024. PMID: 37919448 Free PMC article. Clinical Trial.

2

[Efficacy of FORFIRI regimen on oxaliplatin-based chemotherapy-failed advanced colorectal cancer].

Li YH, Wang FH, Zhang DS, Wang ZQ, Feng F, Zhang L, Xu RH, Jiang WQ, He YJ. Li YH, et al. Ai Zheng. 2009 Sep;28(9):913-8. doi: 10.5732/cjc.008.10571. Ai Zheng. 2009. PMID: 19728906 Free article. Clinical Trial. Chinese.

3

[Clinical significance of a transient increase in carcinoembryonic antigen and carbohydrate antigen 19-9 in patients with metastatic colorectal cancer receiving chemotherapy].

Li YH, An X, Xiang XJ, Wang ZQ, Wang FH, Feng F, Jiang WQ, He YJ, Xu RH. Li YH, et al. Ai Zheng. 2009 Sep;28(9):939-44. doi: 10.5732/cjc.009.10001. Ai Zheng. 2009. PMID: 19728911 Free article. Chinese.

4

[Clinical features of hypersensitivity reactions to oxaliplatin among Chinese colorectal cancer patients].

Zhao Y, An X, Xiang XJ, Feng F, Wang FH, Wang ZQ, Xu RH, He YJ, Li YH. Zhao Y, et al. Among authors: li yh. Chin J Cancer. 2010 Jan;29(1):102-5. doi: 10.5732/cjc.009.10179. Chin J Cancer. 2010. PMID: 20038320 Free article. Chinese.

5

Cutoff value of carcinoembryonic antigen and carbohydrate antigen 19-9 elevation levels for monitoring recurrence in patients with resectable gastric adenocarcinoma.

Qiu MZ, Lin JZ, Wang ZQ, Wang FH, Pan ZZ, Luo HY, Li YH, Zhou ZW, He YJ, Xu RH. Qiu MZ, et al. Among authors: li yh. Int J Biol Markers. 2009 Oct-Dec;24(4):258-64. doi: 10.1177/172460080902400407. Int J Biol Markers. 2009. PMID: 20082274 Free article.

6

Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy.

An X, Ding PR, Xiang XJ, Wang ZQ, Wang FH, Feng F, Jiang WQ, He YJ, Xu RH, Li YH. An X, et al. Among authors: li yh. Biomarkers. 2010 May;15(3):243-8. doi: 10.3109/13547500903477377. Biomarkers. 2010. PMID: 20121626

7

Impact of pretreatment hematologic profile on survival of colorectal cancer patients.

Qiu MZ, Yuan ZY, Luo HY, Ruan DY, Wang ZQ, Wang FH, Li YH, Xu RH. Qiu MZ, et al. Among authors: li yh. Tumour Biol. 2010 Aug;31(4):255-60. doi: 10.1007/s13277-010-0024-x. Epub 2010 Mar 25. Tumour Biol. 2010. PMID: 20336401

8

Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer.

An X, Ding PR, Li YH, Wang FH, Shi YX, Wang ZQ, He YJ, Xu RH, Jiang WQ. An X, et al. Among authors: li yh. Biomarkers. 2010 Sep;15(6):516-22. doi: 10.3109/1354750X.2010.491557. Biomarkers. 2010. PMID: 20602543

9

Incidence of anemia, leukocytosis, and thrombocytosis in patients with solid tumors in China.

Qiu MZ, Xu RH, Ruan DY, Li ZH, Luo HY, Teng KY, Wang ZQ, Li YH, Jiang WQ. Qiu MZ, et al. Among authors: li yh, li zh. Tumour Biol. 2010 Dec;31(6):633-41. doi: 10.1007/s13277-010-0079-8. Epub 2010 Jul 23. Tumour Biol. 2010. PMID: 20652781

10

Expressions of hypoxia-inducible factor-1α and hexokinase-II in gastric adenocarcinoma: the impact on prognosis and correlation to clinicopathologic features.

Qiu MZ, Han B, Luo HY, Zhou ZW, Wang ZQ, Wang FH, Li YH, Xu RH. Qiu MZ, et al. Among authors: li yh. Tumour Biol. 2011 Feb;32(1):159-66. doi: 10.1007/s13277-010-0109-6. Epub 2010 Sep 16. Tumour Biol. 2011. PMID: 20845004

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,540 results

Search Page

Filters